Granules India’s Gagillapur facility classified as “Official Action Indicated” following US FDA… EP News Bureau Dec 3, 2024 Company responds to observations and initiates improvements in collaboration with external experts
US FDA designates Cipla’s Goa plant as ‘Official Action Indicated’ PTI Nov 25, 2022 The US FDA may continue to withhold product approvals from this facility till the outstanding observations are resolved
US FDA cautions Aurobindo Pharma’s oral solids formulation facility of regulatory action Press Trust of India Feb 3, 2020 According to US FDA's definitions, OAI means "objectionable conditions were found and regulatory administrative sanctions by FDA…
Torrent Pharma gets warning letter from US FDA for Gujarat facility Press Trust of India Oct 10, 2019 The company is committed in maintaining the highest standards of compliances and quality manufacturing across all its facilities…